Vilnius University, Institute of Biotechnology, Graiciuno 8, LT-02241 Vilnius, Lithuania.
Virus Res. 2012 Jan;163(1):2-10. doi: 10.1016/j.virusres.2011.08.003. Epub 2011 Aug 16.
Hamster polyomavirus (HaPyV) major capsid protein VP1 based chimeric virus-like particles (VLPs) carrying model GP33 CTL epitope derived from Lymphocytic choriomeningitis virus (LCMV) were generated in yeast and examined for their capability to induce CTL response in mice. Chimeric VP1-GP33 VLPs were effectively processed in antigen presenting cells in vitro and in vivo and induced antigen-specific CD8+ T cell proliferation. Mice immunized only once with VP1-GP33 VLPs without adjuvant developed an effective GP33-specific memory T cell response: 70% were fully and 30% partially protected from LCMV infection. Moreover, aggressive growth of tumors expressing GP33 was significantly delayed in these mice in vivo. Therefore, HaPyV VP1-derived VLP harboring CTL epitopes are attractive vaccine candidates for the induction of insert-specific CTL immune response.
仓鼠多瘤病毒(HaPyV)主要衣壳蛋白 VP1 基于嵌合病毒样颗粒(VLPs)携带来自淋巴细胞性脉络丛脑膜炎病毒(LCMV)的模型 GP33 CTL 表位,在酵母中生成,并在小鼠中检查其诱导 CTL 反应的能力。嵌合 VP1-GP33 VLPs 可在体外和体内有效在抗原提呈细胞中加工,并诱导抗原特异性 CD8+T 细胞增殖。仅用 VP1-GP33 VLPs 免疫一次而不使用佐剂的小鼠可产生有效的 GP33 特异性记忆 T 细胞反应:70%的小鼠完全保护,30%的小鼠部分保护免受 LCMV 感染。此外,这些小鼠体内表达 GP33 的肿瘤生长明显延迟。因此,携带 CTL 表位的 HaPyV VP1 衍生 VLP 是诱导插入特异性 CTL 免疫反应的有吸引力的疫苗候选物。